1.
Weidinger S, Silverberg J, Toth D, Bieber T, Alexis A, Elewski B, Pink A, Hignen D. Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial. J of Skin [Internet]. 2020Oct.27 [cited 2021Jan.25];4(6):s102. Available from: https://jofskin.org/index.php/skin/article/view/1079